Tamoxifen by Hilma Biocar
- Brand: Hilma Biocare
- Generic Name: Tamoxifen Citrate
- Concentration: Typically 20 mg per tablet
- Chemical Formula:
$$C_{26}H_{29}NO$$
- Drug Class: Selective Estrogen Receptor Modulator (SERM)
Mechanism of Action
Tamoxifen is a non-steroidal agent that exerts its effect by binding to estrogen receptors in various tissues.
- In Breast Tissue: It acts as an antagonist, blocking estrogen from attaching to receptors. This inhibits the growth of estrogen-sensitive tumors.
- In Other Tissues (e.g., Bone/Liver): It can act as a partial agonist, mimicking estrogen’s beneficial effects, such as maintaining bone density and improving lipid profiles.
Common Applications
- Medical Treatment: FDA-approved for the treatment and prevention of hormone-receptor-positive breast cancer in both women and men.
- Hormonal Regulation: Used to address gynecomastia (enlargement of male breast tissue).
- Post-Cycle Recovery: In specific performance contexts, it is used to stimulate the pituitary gland to release LH (luteinizing hormone) and FSH (follicle-stimulating hormone), which aids in the restoration of natural testosterone production.
Standard Dosing Guidelines
- For Breast Cancer: Typically 20 mg to 40 mg daily. Doses above 20 mg are usually split into morning and evening administrations.
- For Hormonal Recovery: Usually 20 mg daily for a duration of 4 to 6 weeks, depending on the specific recovery protocol.
Safety & Precautions
- Common Side Effects: Hot flashes, nausea, headache, and leg cramps.
- Serious Risks: Increased risk of blood clots (DVT/PE), stroke, and in long-term female users, uterine cancer.
- Interactions: Should not be used alongside certain antidepressants (like Fluoxetine or Paroxetine) which can inhibit the enzyme (CYP2D6) required to convert Tamoxifen into its active form.
Tamoxifen (nolva), Hilma
- Brand: Hilma Biocare
- Product Code: HLM12
- Availability: 999
-
$47.00

